冷泉港实验室成立于1890年，是一家私人非营利性的科研实验室，通过癌症、神经科学、植物生物学和定量生物学方面的计划塑造了当代生物医学研究和教育。实验室拥有8位诺贝尔奖获得者和1000名员工，其中包括600名科学家、学生和技术人员。会议和课程计划每年在长岛和中国苏州的校园里接待来自世界各地的12000多名科学家。该实验室的教育部门还包括一家学术出版社，一所研究生院以及针对初中，高中和本科生和教师的计划。
实验室以分子生物学研究为使命，始终走在时代前沿，以自身的科研成果、教育宣传和影响力帮助现代科学塑造发展，并与外界进行紧密合作，共同促进科技繁荣，造福全人类。通过与其他大学，医院以及生物技术和制药领域的科学家合作，实验室的研究得到了丰富。实验室科学家的创新精神，远见和才华继续使CSHL跻身已发表研究中引用最多的生命科学机构的前1%之列。
冷泉港实验室将继承一百多年来的科研精神，继续将基础研究和应用研究将结合，促进癌症治愈、食品安全、转基因作物和个性化医疗等不断发展。在未来几年，实验室的研究人员将扩展开发的非凡基础设施，使用分子和细胞技术来做出改善人类状况的发现。
Founded in 1890, Cold Spring Harbor Laboratories is a private, non-profit research laboratory that has shaped contemporary biomedical research and education through programs in cancer, neuroscience, plant biology, and quantitative biology. The laboratory has 8 Nobel Laureates and 1,000 employees, including 600 scientists, students and technicians. Conferences and course programs host more than 12,000 scientists from around the world each year on campuses in Long Island and Suzhou, China. The lab's education department also includes an academic publishing house, a graduate school, and programs for middle, high, and undergraduate and faculty.
With the mission of molecular biology research, the laboratory has always been at the forefront of the times, helping modern science shape development with its own scientific research achievements, educational publicity and influence, and working closely with the outside world to jointly promote the prosperity of science and technology and benefit all mankind. Research in the laboratory is enriched by collaboration with scientists from other universities, hospitals, and the fields of biotechnology and pharmaceuticals. The innovative spirit, vision, and talent of lab scientists continue to make CSHL one of the top 1 percent of life sciences institutions with the most cited studies published.
Cold Spring Harbor Laboratory will inherit the spirit of scientific research for more than 100 years, and continue to combine basic and applied research to promote the continuous development of cancer cure, food safety, genetically modified crops and personalized medicine. In the coming years, researchers in the lab will expand the extraordinary infrastructure developed, using molecular and cellular technologies to make discoveries that improve the human condition.